Spectrum of prenatally diagnosed neural tube defects at a tertiary referral hospital in North India: a retrospective cohort study

Despite the widespread implementation of folic acid supplementation recommendations and fortification programmes, a significant number of cases of neural tube defects (NTDs) still exist. The global estimates suggest that more than 300,000 babies each year are born with NTDs. The incidence of these birth defects in developing nations is about four times higher than in developed ones. NTDs are among the major congenital anomalies which consists mainly of anencephaly, spina bifida and encephalocele, the first two being most common. NTDs, although largely preventable, constitute an important cause of neonatal mortality and morbidity. These birth defects constitute 10% of the burden of all congenital anomalies and accounts for 10% of all neonatal mortality worldwide. The health care of a child with NTD imposes ABSTRACT

[1]  M. Phipps,et al.  Folic Acid Supplementation for the Prevention of Neural Tube Defects: US Preventive Services Task Force Recommendation Statement , 2017, JAMA.

[2]  K. Nasri,et al.  Epidemiology of neural tube defect subtypes in Tunisia, 1991-2011. , 2014, Pathology, research and practice.

[3]  A. Adeleye,et al.  Determinants of folic acid intake during preconception and in early pregnancy by mothers in Ibadan, Nigeria , 2014, The Pan African medical journal.

[4]  A. Kar,et al.  Systematic review of birth prevalence of neural tube defects in India. , 2013, Birth defects research. Part A, Clinical and molecular teratology.

[5]  Rinku Sharma,et al.  Birth defects in India: Hidden truth, need for urgent attention , 2013, Indian journal of human genetics.

[6]  A. Nelson Folates for reduction of risk of neural tube defects: using oral contraceptives as a source of folate , 2011 .

[7]  Z. Amarin,et al.  Neural Tube Defects in the North of Jordan: Is There a Seasonal Variation? , 2010, Journal of child neurology.

[8]  O. Devine,et al.  Folic acid intake among U.S. women aged 15-44 years, National Health and Nutrition Examination Survey, 2003-2006. , 2010, American journal of preventive medicine.

[9]  S. Cousens,et al.  Folic acid to reduce neonatal mortality from neural tube disorders , 2010, International journal of epidemiology.

[10]  A. Ashley-Koch,et al.  Epidemiologic and genetic aspects of spina bifida and other neural tube defects. , 2010, Developmental disabilities research reviews.

[11]  Jane A. Evans,et al.  Reduction in neural-tube defects after folic acid fortification in Canada. , 2007, The New England journal of medicine.

[12]  A. R. Vieira,et al.  Birth order and neural tube defects: a reappraisal , 2004, Journal of the Neurological Sciences.

[13]  J. Halliday,et al.  Neural tube defects in Victoria, Australia: potential contributing factors and public health implications , 2000, Australian and New Zealand journal of public health.

[14]  D. Gray,et al.  Sensitivity and specificity of ultrasound for the detection of neural tube and ventral wall defects in a high-risk population. , 1999, Obstetrics and gynecology.

[15]  J. Zlotogora Hereditary disorders among Iranian Jews. , 1995, American journal of medical genetics.

[16]  J. Sharma,et al.  Potential relationship between dengue fever and neural tube defects in a Northern District of India , 1992, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.